Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.93 USD | -0.01% | -2.36% | -13.08% |
Mar. 21 | Transcript : MiNK Therapeutics, Inc., Q4 2023 Earnings Call, Mar 21, 2024 | |
Mar. 21 | MiNK Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 32.27M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -36M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.81
x | P/E ratio 2025 * |
-1.4
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 28.67% |
Latest transcript on MiNK Therapeutics, Inc.
1 day | -0.01% | ||
1 week | -2.36% | ||
Current month | -6.06% | ||
1 month | -29.55% | ||
3 months | +8.13% | ||
6 months | -21.85% | ||
Current year | -13.08% |
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Buell
CEO | Chief Executive Officer | 50 | 21-01-31 |
Heather Boussios
CMP | Compliance Officer | - | - |
Marc van Dijk
CTO | Chief Tech/Sci/R&D Officer | 61 | 20-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
CHM | Chairman | 71 | 17-06-30 |
Director/Board Member | 66 | 17-06-30 | |
Barbara Ryan
BRD | Director/Board Member | 64 | 21-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.93 | -0.01% | 18,972 |
24-05-07 | 0.9301 | -1.13% | 58,845 |
24-05-06 | 0.9407 | -4.01% | 119,485 |
24-05-03 | 0.98 | +1.09% | 29,534 |
24-05-02 | 0.9694 | +1.77% | 40,322 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.08% | 32.28M | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- INKT Stock